There is little evidence on rates of stent thrombosis (ST) in patients receiving dual antiplatelet therapy (DAPT) with ticagrelor or prasugrel. The aim of this study was to analyze the incidence and predictors of ST after an acute coronary syndrome among patients receiving DAPT with ticagrelor vs prasugrel.
|Titolo:||Annual incidence of confirmed stent thrombosis and clinical predictors in patients with ACS treated with ticagrelor or prasugrel|
|Data di pubblicazione:||2019|
|Digital Object Identifier (DOI):||10.1016/j.rec.2018.05.021|
|Appare nelle tipologie:||1.1 Articolo in rivista|